Success Stories: EB-1A Approved for a Postdoctoral Researcher in Rhode Island in the Field of Pharmaceutics
Client’s Testimonial:
[I’m] totally satisfy with your service, I actually had recommended your firm to my surrounding friends. 1. Your firm did carefully read and understand my research summary; 2. Your firm can give me a reply in time each time. Thank you very much.
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Rhode Island
Approval Notice Date: August 25, 2014
Processing Time: 25 Days (7 days after upgrading to Premium Processing)
In this case, the client that we had the pleasure of working with was Postdoctoral Researcher from China in the field of Pharmaceutics. His specialized research has focused on designing new drug delivery systems that are safe, efficient, and address implementation issues, such as the blood-brain barrier. His work had resulted in 22 peer-reviewed scientific articles, one book chapter and one patent. At the time that his case was filed, his publications had been cited at least 411 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also conducted 29 manuscript reviews for at least 6 distinctive, internationally circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client]’s work is particularly important because both gold and copper sulfide nanomaterials have been consistently used without sufficient data to support their safety. While their effectiveness is welcome in the fight against cancer, causing irreversible damage to human tissue and introducing toxicity into the body in the process is ultimately unacceptable. [Client]’s findings, therefore, are essential in devising appropriate therapeutic strategies for the photothermal ablation of cancer.”” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutics, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 25 days.